|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Ming-Fong Chen | Yu-Cheng Lee | Yu-Cheng Lee | 04-2321-3838 | Rm. I, 8F., No. 573,Sec. 2, Taiwan Blvd.,West Dist.Taiwan Taichung City | 2023/03/01 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | EverFortune.AI established the first cooperation with China Medical University Hospital, and assisted in the construction of “Image Labeling System”, “Image Structured Database” and “Big Data Database”, managing the big data that the hospital has into training material for deep learning. Current results include “Artificial Intelligence Assessment System for Growth Hormone Deficiency and Precocious Disorder Syndrome”, “Gene Sequence Analysis for Uncommon Disorders”, “Artificial Intelligence Assisted Breast Ultrasound Tumor Classification System”, and “Liver Health Assessment and Management System” and many other medical AI-assisted applications. The medical AI cloud server was completed to serve 16 hospitals under the China Medical University Hospital organization, to establish smart hospitals assisted by medical AI. |
Market Information ( 2023/06/02 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
681.027 | 99.80 | 97.60 | 98.20 | 1.20 | 687 | N/A | N/A | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2023/06/02) |
TPEx measures adopted (2023/06/02) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
![]() |
![]() |
![]() |